A Japanese Post-marketing Surveillance of Cetuximab (Erbitux(®)) in Patients with Metastatic Colorectal Cancer

OBJECTIVE: Cetuximab (Erbitux(®)) was approved for the treatment of metastatic colorectal cancer in Japan in 2008. To verify information on the safety in practical use of cetuximab, we conducted post-marketing surveillance in accordance with the conditions for approval. METHODS: All patients to be t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Megumi, Watanabe, Toshiaki, Yamaguchi, Kensei, Satoh, Taroh, Ito, Hideyuki, Seriu, Taku, Sakata, Yuh, Sugihara, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314322/
https://www.ncbi.nlm.nih.gov/pubmed/22327124
http://dx.doi.org/10.1093/jjco/hys005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314322/
https://www.ncbi.nlm.nih.gov/pubmed/22327124
http://dx.doi.org/10.1093/jjco/hys005

Ejemplares similares